Description: Recombinant, Influenza Hemagglutinin Full-Length Glycoprotein (rHA GP) from virus strain A/Hong Kong/33982/2009 (H9N2). Recombinant HA is supplied as an affinity purified protein. rHA is produced in Sf9 insect cells using baculovirus for expression and is purified by FPLC. Size: 50 µg of protein is supplied at a concentration of 0.33 mg/mL (by BCA) in Tris buffered saline plus 0.01% non-ionic detergent. The theoretical molecular weight of the protein is ~63 kDa, without glycosylation. Because of the highly glycosylated nature of this protein, migration in an SDS-PAGE gel is slowed resulting in broad, diffuse bands representing differing glycosylation forms Purity: Residual baculovirus GP64 co-purifies with the affinity purified rHA GP and was determined to be less the 10% of the total protein. Relevance: Recombinant hemagglutinin glycoprotein provides a control protein for immunoassays and a tool to enhance Orthomyxovirus research. Western Blot: Quality control testing demonstrates detection of GP null under reduced conditions when using anti-H9 influenza antiserum Hemagglutination with Turkey Red Blood Cells: HA Titer 1:32,768 Storage: 2-3 weeks at -20°C, -80°C long term Intended for research use only, not for human, therapeutic, or diagnostic applications.
- UPC:
- 41122409
- Condition:
- New
- Availability:
- 3 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 1503-001
